The global Peripheral Neuropathy market garnered revenue around USD XX Billion in 2019 and projected to reach USD 292 Million in 2027, with at a compound annual growth rate of 3.1% throughout the estimate period from 2020 to 2027.
Peripheral neuropathy is a result of damage to the nerves outside of the brain, and spinal cord (peripheral nerves) causes numbness and pain, also weakness in your hands and feet. It can also affect other areas of your body. As peripheral neuropathy If left untreated, leads to serious effects, such as burning pain or paralysis; hence, companies are investing in this market to find the new drugs and treatment methods.
Increasing mergers & acquisitions by prominent players in the market. As the acquisition and mergers facilitate the companies to enter the new market with innovative technologies. For instance, In June 2016, Merck & Co. acquired Afferent Pharmaceuticals to expand the pharma giant's pipeline for treating neurogenic conditions.
This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.
The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Peripheral Neuropathy market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Peripheral Neuropathy market growth.
The global Peripheral Neuropathy market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.
Major manufacturers analysed under this study comprises:
Abbott Laboratories (US)
Bristol Myers Squibb (US)
Novartis AG (UK)
Eli Lilly and Company (US)
Pfizer Inc (US)
GlaxoSmithKline plc (UK)
Merck and Co. Inc. (US)
Cipla Limited (India)
Lupin Limited (India)
Reddy's Laboratories (India)
Hoffmann-La Roche Ltd. (UK)
RxFunction, Inc. (US)
This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:
By Type
Diabetic Peripheral Neuropathy (DPN):
Chemotherapy-induced Peripheral Neuropathy (CIPN):
Idiopathic Peripheral Neuropathy:
HIV/AIDS Associated Peripheral Neuropathy:
By Treatment
Pharmacological Therapies:
Non-Pharmacological Therapies
Others:
By End-User
Hospitals and Clinics:
Ambulatory Centers:
Others:
Regional Analysis and Forecast
Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:
North America
? U.S.
? Canada
Europe
? Germany
? U.K.
? Italy
? France
? Rest of EU
Asia Pacific
? China
? India
? Japan
? Southeast Asia
? Rest of APAC
Central & South America
? Brazil
? Argentina
? Rest of Central & South America
Middle East and Africa
? UAE
? Saudi Arabia
? Rest of MEA
Request Customization
Get a Sample
Get a Sample
Request Customization